photo free
Home Images Vectors Videos

Stock image Paxlovid - new antiviral drug developed by Pfizer

Stock image Paxlovid - new antiviral drug developed by Pfizer
Published: Nov.16, 2021 11:06:41
Author: golib.tolibov.gmail.com
Views: 10
Downloads: 3
File type: image / jpg
File size: 6.92 MB
Orginal size: 5168 x 3448 px
Available sizes:
S
(500 x 334)
M
(1000 x 667)
L
(2000 x 1334)
XL
(5168 x 3448)
EL0
(5168 x 3448)
Level: silver
Download Image
Image topics:

Similar stock images

stock image Paxlovid - new antiviral drug developed by Pfizer

Paxlovid - New Antiviral Drug Developed By Pfizer

4990 × 3330
stock image Paxlovid - new antiviral drug developed by Pfizer

Paxlovid - New Antiviral Drug Developed By Pfizer

4730 × 3156
stock image Paxlovid - new antiviral drug developed by Pfizer

Paxlovid - New Antiviral Drug Developed By Pfizer

5036 × 3360
stock image Bucharest, Romania - February 1, 2022: Illustrative editorial concept image of oral antiviral drug pill Paxlovid developed by Pfizer. Corona virus Covid-19 treatment.

Bucharest, Romania - February 1, 2022: Illustrative Editorial Concept Image Of Oral Antiviral Drug Pill Paxlovid Developed By Pfizer. Corona Virus Covid-19 Treatment.

6516 × 4344
stock image New York, USA - 08 November 2020. Concept of antiviral pill against coronavirus disease. COVID drugs on a medical glass table. Selective focus

New York, USA - 08 November 2020. Concept Of Antiviral Pill Against Coronavirus Disease. COVID Drugs On A Medical Glass Table. Selective Focus

4442 × 2961
stock image United States - december, 16, 2021 Pfizers Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89 in Interim Analysis of Phase 23 EPIC-HR Study

United States - December, 16, 2021 Pfizers Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89 In Interim Analysis Of Phase 23 EPIC-HR Study

4720 × 4550
stock image United States - december, 16, 2021 Pfizers Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89 in Interim Analysis of Phase 23 EPIC-HR Study

United States - December, 16, 2021 Pfizers Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89 In Interim Analysis Of Phase 23 EPIC-HR Study

4720 × 4558
stock image Bucharest, Romania - February 1, 2022: Illustrative editorial concept image of oral antiviral drug pill Paxlovid developed by Pfizer. Corona virus Covid-19 treatment.

Bucharest, Romania - February 1, 2022: Illustrative Editorial Concept Image Of Oral Antiviral Drug Pill Paxlovid Developed By Pfizer. Corona Virus Covid-19 Treatment.

3861 × 5792